Anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma is difficult to diagnose early, and most patients are already in the late stages of the disease when they are admitted to hospital. The total 5-year survival rate is less than 5%. Recent studies have showed that brucine has a good anti-tumor effect, but high toxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Jian-Min, Yin, Pei-Hao, Li, Qi, Sa, Zhong-Qiu, Sheng, Xia, Yang, Lin, Huang, Tao, Zhang, Min, Gao, Ke-Pan, Chen, Qing-Hua, Ma, Jing-Wei, Shen, He-Bai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273973/
https://www.ncbi.nlm.nih.gov/pubmed/22334771
http://dx.doi.org/10.2147/IJN.S27226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273973/
https://www.ncbi.nlm.nih.gov/pubmed/22334771
http://dx.doi.org/10.2147/IJN.S27226

Ejemplares similares